Coreline Soft Strengthens Collaboration with 3DR Labs, the Largest US Company Based on FDA Certification

Coreline Soft announced on the 17th that it will strengthen its collaboration with the largest medical imaging solution company in the United States, 3DR Labs, based on its world-class artificial intelligence (AI) technology. As part of the collaboration enhancement strategy, the two companies also decided to extend the supply contract for the AI software (SW) ‘AVIEW CAC’.

The contract extension was made at the request of 3DR Labs due to Coreline Soft’s unparalleled AI SW technology. After advancing AVIEW CAC, Coreline Soft recently obtained certification from the U.S. Food and Drug Administration (FDA), accelerating its global market expansion. In particular, through international academic journals, it has proven that its AI technology is superior to that of the world’s number one imaging diagnostics company, leading to continuous requests for software adoption from global companies.

AVIEW CAC is an AI software for diagnosing coronary artery disease, which accounts for 39.5% of all cardiovascular disease deaths. Recently, due to the surge in demand for cardiovascular disease diagnosis in the U.S., 3DR Labs has installed AVIEW CAC on more than half of its existing software and is expanding its application.

Coreline Soft plans to diversify the AI software applied through strengthened collaboration with 3DR Labs. AVIEW CAC is highly regarded by local U.S. specialists not only for its excellent performance but also for its optimized reading report functionality. The company explained that it is currently discussing with 3DR Labs to supply additional AI software based on its differentiated AI technology, beyond AVIEW CAC.

A Coreline Soft representative said, “Our proprietary AI software has received favorable reviews from U.S. clinicians based on its outstanding performance and interoperability, and 3DR Labs requested an extension of the supply contract to expand the application of AVIEW CAC.” He added, “3DR Labs is expanding the supply of telemedicine solutions across various medical fields, and since AVIEW CAC has excellent interoperability, its usage within U.S. medical institutions is expected to continue increasing.”

He continued, “In the U.S., the prevalence and treatment costs of cardiovascular diseases are continuously rising, leading to a surge in early diagnosis demand for high-risk coronary artery disease. We will strengthen our partnership with 3DR Labs, the world’s leading medical AI company, to diversify the adoption of our software and expand AI software supply within the U.S.”

3DR Labs is the largest 3D (three-dimensional) medical imaging post-processing specialist company in the U.S., with a network of over 1,000 global hospitals and radiology centers. Utilizing its own specialized technical personnel and advanced imaging software, it enables rapid analysis of imaging readings such as CT (computed tomography) scans and remotely conducts readings by receiving medical images from medical institutions.

This content was produced with the assistance of AI translation services.